Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Corbus Pharmaceuticals Hldgs Inc (CRBP)
Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Corbus Pharmaceuticals: Q2 Earnings Snapshot AP - Tue Aug 8, 8:08AM CDT

Corbus Pharmaceuticals: Q2 Earnings Snapshot

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update PR Newswire - Tue Aug 8, 7:00AM CDT

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today provided a corporate...

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference PR Newswire - Mon Jul 31, 7:00AM CDT

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval...

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals: Q1 Earnings Snapshot AP - Tue May 9, 7:11AM CDT

Corbus Pharmaceuticals: Q1 Earnings Snapshot

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting PR Newswire - Mon Apr 17, 7:30AM CDT

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced details of new...

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting PR Newswire - Tue Mar 14, 3:35PM CDT

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an...

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals: Q4 Earnings Snapshot AP - Tue Mar 7, 7:22AM CST

Corbus Pharmaceuticals: Q4 Earnings Snapshot

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update PR Newswire - Tue Mar 7, 7:00AM CST

Company expands precision oncology pipeline with licensing of CRB-701, clinical-stage Nectin-4 antibody drug conjugate (ADC) from CSPC Pharmaceutical Group...

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA PR Newswire - Mon Mar 6, 7:00AM CST

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced the appointment...

CRBP : 6.80 (+4.62%)
Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) PR Newswire - Mon Feb 13, 5:55AM CST

CRB-701 (SYS6002) is designed for improved therapeutic index and to act on a broad range of Nectin-4 expressing tumors Clinical development is underway and...

CRBP : 6.80 (+4.62%)

Barchart Exclusives

Can Warmer Weather Increase Australian Dollar Trader Profits? Barchart - Sat Sep 23, 3:54PM CDT
Australia's second quarter is typically associated with seasonal trends in tourism and travel. The country attracts many international tourists as Australia's weather becomes more favorable during this period. The influx of visitors can influence the demand for the Australian Dollar. Could this put profits in traders' accounts this year? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot